Unveiling 4 Analyst Insights On Oscar Health
Portfolio Pulse from Benzinga Insights
Oscar Health (NYSE:OSCR) has received recent analyst ratings, all of which are somewhat bullish. The average 12-month price target is $26.5, reflecting a slight increase from previous targets. Oscar Health has shown significant revenue growth but lags behind industry peers in net margin. The company demonstrates strong financial management with a high ROE and low debt-to-equity ratio.
September 10, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Oscar Health has received somewhat bullish ratings from analysts, with a 12-month price target of $26.5. The company's revenue growth is notable, but it faces challenges in net margin compared to peers. Strong ROE and low debt-to-equity ratio indicate robust financial management.
The somewhat bullish ratings and increased price target suggest positive sentiment among analysts, likely leading to a short-term price increase. The company's strong financial metrics, such as ROE and debt management, further support this outlook, despite challenges in net margin.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100